000			03879nam a22002895i 4500
001			402924
003			ES-MaUEC
005			20240528105942.0
007			cr nn 008mamaa
008			240108s2023 si | o |||| 0|eng d
020			_a9789819969401
024	7		_a10.1007/978-981-99-6940-1 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aT174.7 _b2023 EB
245	0	0	_aNano Drug Delivery for Cancer Therapy : _bPrinciples and Practices _cedited by Firdos Alam Khan
250			_a1st ed. 2023
264		1	_aSingapore _bSpringer International Publishing _c2023
300			_a1 recurso en línea
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aCh 1 Significance of nano-drug delivery in cancer therapy, application of nanoparticles in overcoming drug resistance, targeted therapy, and Immunotherapy -- Ch 2 Synthesis of different types, shapes, and sizes of nanocarriers using synthetic and biological approaches -- Ch 3 Synthesis of nanocarriers loaded with anti-cancer drugs by using functionalization or conjugations, encapsulation methods -- Ch 4 Nano-Drug Carriers for Chemotherapeutic Agents Delivery in Cancer Disease Treatment -- Ch 5 Testing Of Nanocarriers Loaded with Chemotherapeutic Agents in the Animal Models of Cancers - Preclinical Trials for Efficacy and Safety Profiling of Nanocarriers -- Ch 6 Testing Of Nanocarriers Loaded With Chemotherapeutic Agents In The Animal Models Of Cancers - Preclinical Trials For Efficacy And Safety Profiling Of Nanocarriers -- Ch 7 Nanocarriers-Based Products In The Market, Fda Approval, Commercialization Of Nanocarriers, and Global Market -- Ch 8 Limitations of Nanocarriers Such as Cell and Tissue Toxicity, Genotoxicity, Scale-Up of Nanomaterials -- Ch 9 Health And Environmental Hazards Associated With The Synthesis Of Nanomaterials-Respiratory Diseases, Government Regulations, Ethical Issues -- Ch 10 Future trends and innovation in nano drug delivery for cancer therapy, application of siRNA (nanoparticle-based RNA) therapy, Ultrasound linked nano-cancer therapeutics, and application of exosomes-based cancer therapy.
520			_aThis book discusses the various modes and methods of nano-based drug delivery in different types of cancers such as colon, breast, cervical, ovarian, and lung cancer. It reviews the significance of nano drug delivery in cancer therapy, the application of nanoparticles in overcoming drug resistance, targeted therapy, and immunotherapy. The book also covers topics related to the synthesis of different types, shapes, and sizes of nanocarriers using synthetic and biological approaches. Further, a chapter explores the synthesis of nanocarriers loaded with anti-cancer drugs by using functionalization or conjugations and encapsulation methods. The book also examines the nanocarriers as delivery vehicles for chemotherapeutic agents against cancers using in vitro and animal models of cancers, preclinical trials for efficacy, and safety profiling of nanocarriers. Finally, future trends and innovation in nano drug delivery for cancer therapy, application of siRNA (nanoparticle-based RNA)therapy, ultrasound-linked nano-cancer therapeutics, and application of exosome-based cancer therapy topics are discussed. Towards the end, the book examines the limitations of nanocarriers, including the cell and tissue toxicity, genotoxicity, and scale-up of nanomaterials, health and environmental hazards associated with nanoformulation synthesis, respiratory diseases, government regulations, and ethical issues.
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-99-6940-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
988			_aSpringer_Medicine_2023
999			_c402924 _d402924